skip over navigation

Perry W. Payne, Jr., MD, JD, MPP

Perry W. Payne, Jr. is an Assistant Research Professor in the Department of Health Policy.

Perry W. Payne, Jr., MD, JD, MPP

Concerns about equity and efficiency underlie the many topics to which Perry Payne has applied his training in law, medicine, and public policy. At SPHHS, he is part of a legal and policy analysis team using an evidence-based approach to help transform the DC Medical Assistance Administration, which operates the District's Medicaid programs. Dr. Payne is also engaged in research to assess cardiologists' views on the use of race as an indication for prescription drugs.

Before joining SPHHS in 2006, Dr. Payne served as co-investigator of a strategic planning process to create a research center at Howard University focused on the ethical, legal and social implications of genetic research. He also worked as a health insurance specialist for the Center for Medicare and Medicaid Services, drafting regulations for competitive bidding and strengthening the coding process used to determine reimbursement for medical products. As a graduate student, Dr. Payne worked as a program analyst for the Agency for Healthcare Research and Quality, where he reviewed the State Child Health Insurance Program (SCHIP) and studied disparities in children's health services.

When he is not pursuing his scholarly interests in health policy, health law and health disparities, Dr. Payne may be studying Mandarin or Luganda, increasing his proficiency in Spanish, training for a marathon, or playing one of his percussion instruments.

Education

Bachelor of Science (Biological Sciences), Stanford University, 1996
Juris Doctor, George Washington University Law School, 2003
Masters of Public Policy, Duke University, 2004
Doctor of Medicine, Duke University School of Medicine, 2004

Teaching

Hirsh Health Law and Policy Residency Rotation in Health Policy, Department of Health Policy
Pharmaceutical Policy, Department of Health Policy(Spring 2008)

Research

Areas of research interest include: the policy implications of genetics research and technologies; equitable distribution of health care technologies and pharmaceuticals; policy factors that affect the translation of medical research into practice; and best practices for improving public health insurance systems.

Community Service

Dr. Payne is a member of both the Genetics Equity Network and the Personalized Medicine Coalition.

Departments

Publications

site maintained by James Kraetz | last updated 05 July 2008 | Site Map